Pyxis Oncology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Pyxis Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
- Pyxis Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$17.3M, a 8.8% decline year-over-year.
- Pyxis Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$59.2M, a 40.2% increase year-over-year.
- Pyxis Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$73.8M, a 38.9% increase from 2022.
- Pyxis Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$121M, a 58.9% decline from 2021.
- Pyxis Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$76M, a 492% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)